Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia. The aim of this trial is to evaluate the efficacy and safety
of repaglinide and metformin combination therapy in Chinese subjects with type 2 diabetes
inadequately controlled with OAD (oral anti-diabetic drugs).